StockData
Merck & Co., Inc. logo

Merck & Co., Inc. (MRK) stock

MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 9/30239% above fair value
$132.81−4.97 (-3.61%)

Close on Nov 19, 2026Market cap $327.67BP/E 106.2Yield 2.47%

Merck shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Merck's shares outstanding was 2.47B at Jun 30, 2026. For fiscal 2025 it was 2.51B, down 1.3% from the year before. Over ten years it grew -1.2% a year on average. The highest annual figure on record is 3.09B in fiscal 2011.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 20252.51B-1.3%
FY2024Dec 31, 20242.54B-0.2%
FY2023Dec 31, 20232.55B+0.2%
FY2022Dec 31, 20222.54B+0.2%
FY2021Dec 31, 20212.54B-0.1%
FY2020Dec 31, 20202.54B-1.5%
FY2019Dec 31, 20192.58B-3.7%
FY2018Dec 31, 20182.68B-2.5%
FY2017Dec 31, 20172.75B-1.4%
FY2016Dec 31, 20162.79B-1.9%
FY2015Dec 31, 20152.84B-3.0%
FY2014Dec 31, 20142.93B-2.3%
FY2013Dec 31, 20133.00B-2.6%
FY2012Dec 31, 20123.08B-0.6%
FY2011Dec 31, 20113.09B+99166566.7%
FY2010Dec 31, 20100M-100.0%
FY2009Dec 31, 20092.27B+6.1%
FY2008Dec 31, 20082.14B–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 20262.47B-1.7%
Q1 FY2026Mar 31, 20262.47B-2.3%
Q4 FY2025Dec 31, 20252.49B-1.9%
Q3 FY2025Sep 30, 20252.50B-1.7%
Q2 FY2025Jun 30, 20252.51B-1.2%
Q1 FY2025Mar 31, 20252.53B-0.5%
Q4 FY2024Dec 31, 20242.54B-0.2%
Q3 FY2024Sep 30, 20242.54B-0.2%
Q2 FY2024Jun 30, 20242.54B+0.2%
Q1 FY2024Mar 31, 20242.54B-0.3%
Q4 FY2023Dec 31, 20232.54B-0.3%
Q3 FY2023Sep 30, 20232.55B+0.2%
Q2 FY2023Jun 30, 20232.54B-0.0%
Q1 FY2023Mar 31, 20232.55B+0.6%
Q4 FY2022Dec 31, 20222.55B+0.5%
Q3 FY2022Sep 30, 20222.54B+0.2%
Q2 FY2022Jun 30, 20222.54B0.0%
Q1 FY2022Mar 31, 20222.54B-0.2%
Q4 FY2021Dec 31, 20212.54B-0.2%
Q3 FY2021Sep 30, 20212.54B-0.1%
Q2 FY2021Jun 30, 20212.54B+0.2%
Q1 FY2021Mar 31, 20212.54B-0.2%
Q4 FY2020Dec 31, 20202.54B-0.7%
Q3 FY2020Sep 30, 20202.54B-1.3%
Q2 FY2020Jun 30, 20202.54B-2.0%
Q1 FY2020Mar 31, 20202.55B-2.2%
Q4 FY2019Dec 31, 20192.56B-2.8%
Q3 FY2019Sep 30, 20192.57B-4.0%
Q2 FY2019Jun 30, 20192.59B-4.0%
Q1 FY2019Mar 31, 20192.60B-3.9%
Q4 FY2018Dec 31, 20182.63B-3.5%
Q3 FY2018Sep 30, 20182.68B-1.8%
Q2 FY2018Jun 30, 20182.70B-2.0%
Q1 FY2018Mar 31, 20182.71B-2.0%
Q4 FY2017Dec 31, 20172.73B-1.6%
Q3 FY2017Sep 30, 20172.73B-2.1%
Q2 FY2017Jun 30, 20172.75B–
Q1 FY2017Mar 31, 20172.77B–
Q4 FY2016Dec 31, 20162.77B–
Q3 FY2016Sep 30, 20162.79B–

More Merck figures

See a number that looks wrong?